Louisiana has officially banned kratom as a Schedule I substance, leading to arrests, raids, and controversy. Learn how the state’s for-profit prison system may be driving aggressive enforcement — and what this means for kratom consumers.
Governor Mike DeWine (R-Ohio) is urging the Ohio Board of Pharmacy (BOP) to classify kratom as a Schedule I substance. This comes just weeks after the Food and Drug Administration’s (FDA) recommendation that the Drug Enforcement Administration (DEA) schedule 7-hydroxymitragynine (7-OH), an alkaloid that occurs in trace amounts in plain leaf kratom and as a …
Ohio Governor Calls for State Kratom Ban; Cites Recent FDA Recommendation Read More »
Just two days after the FDA announced plans to recommend that the DEA schedule 7-hydroxymitragynine (7-OH) as a controlled substance, on July 31, council members in Toledo, Ohio announced a possible ban on all of kratom, as well as legislation that would urge the state to ban as well. The ban in Toledo would only …
Toledo Ohio Debates Kratom Ban and Push for State Ban Read More »
Florida Attorney General James Uthmeier has filed an emergency rule that classifies 7-hydroxymitragynine (7-OH) a Schedule I substance in Florida. “Due to the danger posed to the public, Florida is taking 7-OH off the shelves immediately,” said Uthmeier in a news release. “We are here today because Dr. Marty Makary and the FDA have alerted …
Will Florida’s 7-OH Ban Set Off a Domino Effect? Read More »
The alkaloid 7-hydroxymitragynine (7-OH) is unique in that it occurs mostly as a metabolite of mitragynine (MG), the most abundant alkaloid in kratom. On July 29, the Food and Drug Administration (FDA) announced its intention to recommend scheduling of 7-OH on the list of federally controlled substances, but explicitly stated that its not going after …
Could Kratom Consumers Catch DUI if 7-OH is Banned? Read More »
A wave of negative media coverage (more than usual) has engulfed kratom in the weeks following the FDA’s July 29 recommendation to classify 7-hydroxymitragynine (7-OH) as an illicit substance. While the agency’s move targets products containing an abundance of 7-OH—not the plain leaf kratom that contains near-zero amounts of 7-OH—news outlets have blurred the distinction, …
Wave of Negative News Engulfs Kratom Since FDA Move to Schedule 7-OH Read More »
This past spring, state lawmakers have filed six bills in Massachusetts having to do with kratom policy. Four of the bills aim to schedule kratom as a “Class A” controlled substance, which would put it in the same category as heroin and fentanyl. One bill, S1558, aims to regulate kratom similar to Kratom Consumer Protection …
Multiple Kratom Ban Bills Sit in Massachusetts Legislature Read More »
On Tuesday, July 29, officials including Department of Health and Human Services (HHS) Secretary Robert F. Kennedy, Jr. and Food and Drug Administration (FDA) Commissioner Marty Makary announced via a press conference the FDA’s intent to recommend to the Drug Enforcement Administration (DEA) that 7-hydroxymitragynine (7-OH) be scheduled as a controlled substance. Several times during …
The kratom industry is railing against 7-OH products as problematic, but are extra-strength kratom extracts problematic too? The controversy surrounding the rise of new 7-hydroxymitragynine (7-OH) products has sparked a debate among various players in the kratom industry, as well as scientists and consumers. A debate called “The 7-OH Fault Line” took place at the …
Members of the American Kratom Association (AKA) and the Holistic Alternative Recovery Trust (HART) will debate the controversial alkaloid 7-hydroxymitragynine (7-OH) and the 7-OH-abundant products that have become available to consumers in the past 2 years. Billed as “The 7-OH Fault Line”, the debate will take place at the Las Vegas Convention Center 3150 Paradise …
AKA and HART Face Off Over 7-Hydroxymitragynine This Friday Read More »